Neptune Star Bio, formerly known as Shenzhen Shekou Neptune Star Bio-engineering Co., Ltd., was approved by Shenzhen Nanshan District People's Government on February 3, 20 10, and was established by Shennanfu (1992)18. 1On July 25th, 1996, Shenzhen Securities Regulatory Bureau approved the reorganization of public joint-stock companies with Shenzhen Securities Office's reply (1996) No.68. The invention of the company involved a sustained-release preparation of cepharanthine.
Development.
Significant progress has been made in independent innovation of Neptune's biological tumor drugs. Shenzhen Wanghai Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Wanghai Bio, applied for the patent of "Phenylnitrone Compounds Containing Stilbene Fragments and Their Uses" and was authorized by China National Intellectual Property Administration. ?
According to the patent abstract, the patent can be used to treat hyperproliferative diseases of mammalian cells, such as cancer, and can also be used as a neuroprotective agent. At the same time, the invention also discloses a pharmaceutical composition containing these compounds and its application in preparing anti-tumor drugs.